By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
THis is exciting to have a new effective Rx option for DM pts. Also encouraging is the early data on alpha IFN ihhibition w/ anifrolumab in DM. Definitely present this and get the feedback of your peers!